Therefore, metabolic unbalance caused by NOTCH1 inhibition in T-ALLs forces cells to rely on catabolic pathways to obtain essential metabolites for cell growth, this finding opening new therapeutic avenues to overcome GSI resistance in T-ALL patients. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.